Compound Detail
CHEMBL551466
ACLIDINIUM BROMIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
Basic Information
| ChEMBL ID | CHEMBL551466 |
| Name | ACLIDINIUM BROMIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | XLAKJQPTOJHYDR-QTQXQZBYSA-M |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1194325 |
| Active Moiety | CHEMBL1194325 |
6
Targets
14
Activities
3
Assay Types
4
PK Parameters
20
Publications
17
Known Names
6
Indications
1
Mechanisms
Molecular Properties
484.7
MW (Da)
4.67
ALogP
6
HBA
1
HBD
55.8
PSA (Ų)
0.27
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2012 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Muscarinic acetylcholine receptor M3 antagonist | ANTAGONIST | Muscarinic acetylcholine receptor M3 | ✓ | ✓ |
Indications
Bronchial Spasm Bronchitis, Chronic Emphysema Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Tobacco Use Disorder
ATC Classification
R03BB05
aclidinium bromide
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Activity Summary
IC50 8 meas. best 10.0
Ki 5 meas. best 10.15
Kd 1 meas. best 10.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 10.15 | 9.7 | 0.1 | 2 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | Ki | 10.1 | 9.735 | 0.1 | 2 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 10.1 | 10.1 | 0.1 | 1 |
| Unchecked CHEMBL612545 | Kd | 10.1 | 10.1 | 0.1 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | IC50 | 10.0 | 9.925 | 0.1 | 2 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | IC50 | 9.9 | 9.835 | 0.1 | 2 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | IC50 | 9.9 | 9.835 | 0.1 | 2 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | IC50 | 9.8 | 9.8 | 0.2 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | IC50 | 9.7 | 9.7 | 0.2 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 145.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 145.0 | mL.min-1.g-1 | Homo sapiens |
| T1/2 | 0.03667 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31204225 | 10.1016/j.bmc.2019.06.016 | Mus musculus | 4 |
| 19653626 | 10.1021/jm900132z | Plasma | 4 |
| 24837158 | 10.1016/j.bmc.2014.04.031 | Rattus norvegicus | 3 |
| 19653626 | 10.1021/jm900132z | Cavia porcellus | 3 |
| 19653626 | 10.1021/jm900132z | Muscarinic acetylcholine receptor M2 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 19653626 | 10.1021/jm900132z | Mus musculus | 2 |
| 19653626 | 10.1021/jm900132z | Muscarinic acetylcholine receptor M3 | 2 |
| 19653626 | 10.1021/jm900132z | Muscarinic acetylcholine receptor M1 | 2 |
| 21036043 | 10.1016/j.bmcl.2010.10.016 | Muscarinic acetylcholine receptor M1 | 1 |
| 21036043 | 10.1016/j.bmcl.2010.10.016 | Muscarinic acetylcholine receptor M3 | 1 |
| 21036043 | 10.1016/j.bmcl.2010.10.016 | Muscarinic acetylcholine receptor M4 | 1 |
| 21036043 | 10.1016/j.bmcl.2010.10.016 | Muscarinic acetylcholine receptor M5 | 1 |
| 22047691 | 10.1016/j.bmcl.2011.10.002 | Unchecked | 1 |
| 22047691 | 10.1016/j.bmcl.2011.10.002 | Plasma | 1 |
| 22047691 | 10.1016/j.bmcl.2011.10.002 | Liver microsomes | 1 |
| 22047691 | 10.1016/j.bmcl.2011.10.002 | Muscarinic acetylcholine receptor M2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Histamine H1 receptor | 1 |
Data from ChEMBL 36 via Core Engine